Product Information
QELBREE ER 100 MG CAPSULE is a brand product labeled by Supernus Pharmaceuticals Inc., priced at $12.7323 per EA under NDC 17772013130. Its NADAC has been published 253 times since Oct 20, 2021.
FDA first approved this application on Apr 2, 2021.
Strength
100 mg/1
Manufacturer
Supernus Pharmaceuticals Inc.NDC
17772013130
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VILOXAZINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA211964FDA Approved
4/2/2021
On Market Since
4/2/2021
Pharmacological Classes
Price Statistics
The NADAC for QELBREE ER 100 MG CAPSULE has been published 253 times since Oct 20, 2021, and over the history we have for it it has risen 33.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.7323 per EA |
|---|---|
| All-time high | $12.7484 (Jun 10, 2026) |
| All-time low | $9.5697 (Oct 20, 2021) |
| 52-week high | $12.7484 |
| 52-week low | $12.0218 |
| Median price | $11.3469 |
| Average price | $11.2281 |
| Largest weekly change | +6.0% (Jan 3, 2024) |
| Weeks tracked | 253 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the viloxazine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QELBREE ER 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QELBREE ER 100 MG CAPSULE, manufactured by Supernus Pharmaceuticals Inc., is $12.7323 per EA (NDC 17772013130), effective Aug 19, 2026.
How has the price of QELBREE ER 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QELBREE ER 100 MG CAPSULE has risen 33.0%. It has been tracked across 253 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for QELBREE ER 100 MG CAPSULE?
Since Oct 20, 2021, the NADAC for QELBREE ER 100 MG CAPSULE has ranged from a low of $9.5697 (Oct 20, 2021) to a high of $12.7484 (Jun 10, 2026), with a median of $11.3469 per EA.
Are there cheaper alternatives to QELBREE ER 100 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of QELBREE ER 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QELBREE ER 100 MG CAPSULE?
QELBREE ER 100 MG CAPSULE (NDC 17772013130) is labeled by Supernus Pharmaceuticals Inc., and CMS classifies it as a brand product.